Skowronski DM, De Serres G, Janjua NZ, Gardy JL, G. Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November. Euro Surveill. 2012;17(4):pii=20066. Full Text submitted by kickingbird at 8 hours ago from Euro Surveill. 2012;17(4):pii=20066 In pre- and post-immunisation sera from children (17–120 months-old) and adults (20–59 years-old) immunised with 2010/11 trivalent inactivated influenza vaccine, we assessed age-related patterns of sero-susceptibility ... Eefje J. A. Schrauwen,etc.,al. The multi basic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. 2012, doi: 10.1128/?JVI.06828-11. Abstract submitted by kickingbird at 8 hours ago from 2012, doi: 10.1128/?JVI.06828-11 The route by which highly pathogenic avian influenza (HPAI) H5N1 virus spreads systemically, including the central nervous system (CNS), is largely unknown in mammals. Especially the olfactory route, which ... FONTANA J, Cardone G, Heymann JB, Winkler DC, et a. Structural changes in influenza virus at low pH characterized by cryo-electron tomography. J Virol. 2012. Abstract submitted by kickingbird at 4 days ago from J Virol. 2012 Influenza virus enters host cells by endocytosis. The low pH of endosomes triggers conformational changes in hemagglutinin (HA) that mediate fusion of the viral and endosomal membranes. We have used cryo-electron ... KOBAYASHI Y, Suzuki Y. Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J Virol. 2012. Abstract submitted by kickingbird at 4 days ago from J Virol. 2012 After the emergence of influenza A viruses in the human population, the number of N-glycosylation sites (NGS) in the globular head region of hemagglutinin (HA) has increased continuously for several decades. ... KANCHANA S, Kanchana S, Chuntrakul C, Malathum K,. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment. J Infect. 2011;63:295-9.. Abstract submitted by kickingbird at 4 days ago from J Infect. 2011;63:295-9. OBJECTIVES:
To study pandemic (H1N1) 2009 virological outcomes after Oseltamivir treatment in confirmed cases of pandemic (H1N1) 2009 virus infections. A hospital-based cohort study was conducted in ... | |